These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Eosinophilic gastroenteritis in a young girl--long term remission under Montelukast. Quack I; Sellin L; Buchner NJ; Theegarten D; Rump LC; Henning BF BMC Gastroenterol; 2005 Jul; 5():24. PubMed ID: 16026609 [TBL] [Abstract][Full Text] [Related]
4. Montelukast as a treatment modality for eosinophilic gastroenteritis. De Maeyer N; Kochuyt AM; Van Moerkercke W; Hiele M Acta Gastroenterol Belg; 2011 Dec; 74(4):570-5. PubMed ID: 22319970 [TBL] [Abstract][Full Text] [Related]
5. Use of montelukast as steroid-sparing agent for recurrent eosinophilic gastroenteritis. Schwartz DA; Pardi DS; Murray JA Dig Dis Sci; 2001 Aug; 46(8):1787-90. PubMed ID: 11508684 [TBL] [Abstract][Full Text] [Related]
6. Successful use of montelukast in eosinophilic gastroenteritis: a case report and a literature review. El-Alali EA; Abukhiran IM; Alhmoud TZ BMC Gastroenterol; 2021 Jul; 21(1):279. PubMed ID: 34238222 [TBL] [Abstract][Full Text] [Related]
7. Therapeutic Hotline: Cysteinyl leukotriene receptor antagonist montelukast in the treatment of atopic dermatitis. Broshtilova V; Gantcheva M Dermatol Ther; 2010; 23(1):90-3. PubMed ID: 20136913 [TBL] [Abstract][Full Text] [Related]
8. Treatment of eosinophilic gastroenteritis with montelukast. Neustrom MR; Friesen C J Allergy Clin Immunol; 1999 Aug; 104(2 Pt 1):506. PubMed ID: 10452782 [No Abstract] [Full Text] [Related]
9. Montelukast in pediatric asthma management. Walia M; Lodha R; Kabra SK Indian J Pediatr; 2006 Apr; 73(4):275-82. PubMed ID: 16816486 [TBL] [Abstract][Full Text] [Related]
10. Eosinophilic oesophagitis: treatment using Montelukast. Sinharay R Gut; 2003 Aug; 52(8):1228-9. PubMed ID: 12865292 [No Abstract] [Full Text] [Related]
11. Montelukast reduces peripheral blood eosinophilia but not tissue eosinophilia or symptoms in a patient with eosinophilic gastroenteritis and esophageal stricture. Daikh BE; Ryan CK; Schwartz RH Ann Allergy Asthma Immunol; 2003 Jan; 90(1):23-7. PubMed ID: 12546333 [TBL] [Abstract][Full Text] [Related]
13. Montelukast: use in pediatric patients with eosinophilic gastrointestinal disease. Vanderhoof JA; Young RJ; Hanner TL; Kettlehut B J Pediatr Gastroenterol Nutr; 2003 Feb; 36(2):293-4. PubMed ID: 12548071 [No Abstract] [Full Text] [Related]
14. Clinical efficacy and pharmacokinetics of montelukast in dyspeptic children with duodenal eosinophilia. Friesen CA; Kearns GL; Andre L; Neustrom M; Roberts CC; Abdel-Rahman SM J Pediatr Gastroenterol Nutr; 2004 Mar; 38(3):343-51. PubMed ID: 15076638 [TBL] [Abstract][Full Text] [Related]
15. Successful treatment of severe atopic dermatitis with cysteinyl leukotriene receptor antagonist montelukast. Angelova-Fischer I; Tsankov N Acta Dermatovenerol Alp Pannonica Adriat; 2005 Sep; 14(3):115-9. PubMed ID: 16200338 [TBL] [Abstract][Full Text] [Related]
16. The Leukotriene Receptor Antagonist Montelukast Reduces Alpha-Synuclein Load and Restores Memory in an Animal Model of Dementia with Lewy Bodies. Marschallinger J; Altendorfer B; Rockenstein E; Holztrattner M; Garnweidner-Raith J; Pillichshammer N; Leister I; Hutter-Paier B; Strempfl K; Unger MS; Chishty M; Felder T; Johnson M; Attems J; Masliah E; Aigner L Neurotherapeutics; 2020 Jul; 17(3):1061-1074. PubMed ID: 32072462 [TBL] [Abstract][Full Text] [Related]
17. Leukotriene receptor antagonism with montelukast as a possible therapeutic for venous thromboembolism prophylaxis: An observational study. Sutton SS; Magagnoli J; Cummings TH; Hardin JW Prostaglandins Other Lipid Mediat; 2022 Aug; 161():106649. PubMed ID: 35595009 [TBL] [Abstract][Full Text] [Related]
18. Malabsorption syndrome and leukotriene inhibitor. Selva Kumar C; Das RR; Balakrishnan CD; Balagurunathan K; Chaudhuri K J Trop Pediatr; 2011 Apr; 57(2):135-7. PubMed ID: 20571153 [TBL] [Abstract][Full Text] [Related]